Top lobbying groups dive into ‘Medicare for All’ debate
As we’ve said, “Medicare for all” would be a bonanza for lobbyists, give government even more control over your treatments, give everyone Medicaid style medicine, and create endless red ink. ( Delete: and terribly expensive for taxpayers.)
(From The Hill)
The debate over “Medicare for All” is seeing big money interests rushing to back both sides, with top lobbying groups registered to both oppose and push for the policy.
Legislation for the single-payer system, introduced in the House in February, has 33 companies registered to lobby on it so far in 2019, including the Pharmaceutical Research and Manufacturers of America (PhRMA), the U.S. Chamber of Commerce, National Retail Federation, Blue Cross Blue Shield, the American Medical Association, and the American Hospital Association.